UK Health secretary Matt Hancock has sought to curb any medicines shortages which could endanger patient health in the event of a ‘no deal’ Brexit from 29 March 2019. Hancock has instructed that the NHS needs to set aside six weeks’ worth of medicines – but according to anti-Brexit campaign group, Best for Britain, this
Although there have been various warnings about the supply train issues that will happen if a so-called “hard Brexit” occurs, the UK and EU have been unable to refine terms on how drugs will move amongst countries. As a result the NHS is also having to scramble to figure out how to mitigate possible drug
The researchers from the Imperial College London have analysed 20 pharmacies that were accessible for ordering from by UK citizens online. The study conducted by Imperial College London is one of the few that take a closer look at online availability of antibiotics and the potential impact it could have on the public health. Antibiotics
On Thursday June 23rd 2016, the UK voted in tens of millions on whether the UK should remain within the European Union. The following day it was announced that the UK will be set to leave the EU with the votes swaying 51.9% for leave and 48.1% for remain, with a 72.2% turnout. In light
Clinical Professionals are delighted to announce that our 2016 Life Sciences Salary Survey is complete and available for delivery. Nine months in the making, the survey was launched with the aim to analyse industry salaries, coms/benefits for core roles throughout the Life Sciences industry (pharma/biotech/CRO): • Clinical Research • Regulatory Affairs • Drug Safety (pharmacovigilance)
New data from the Phase IIIb OTEMTO 1&2 trials show Spiolto Respimat provides consistent and clinically meaningful improvements in quality of life versus placebo in patients with chronic obstructive pulmonary disease (COPD).
A major change to UK patent law which took effect yesterday could help attract more clinical studies to the UK. The amendment to the patent law allows organisations to use a patented product when carrying out clinical trials, removing the risk of infringement claims. The amendment is an addition to the existing ‘Bolar Exemption’, a
Celgene and Bristol-Myers Squibb have founded a clinical trial alliance for a potential new cancer combination therapy. As part of the alliance, the two companies will conduct a Phase I clinical study to assess the safety, tolerability and early efficacy of Bristol-Myers Squibb’s investigational PD-1 immune checkpoint inhibitor Opdivo and Celgene’s chemotherapy Abraxane.
Pfizer yesterday announced that they have agreed to purchase two of Baxter International’s commercially marketed vaccines and part of Baxter’s production facilities for $635 million. The purchase will give Pfizer access to Baxter’s meningitis C jab NeisVac-C and FSME-IMMUN/TicoVac, a vaccine that helps protect against tick-borne encephalitis – an infection of the brain transmitted by
UCB has today announced positive topline clinical results for epilepsy drug, brivaracetam, from their most recent Phase III clinical study. The aim of clinical trial was to assess the effectiveness of brivaracetam as adjunctive treatment in adults not fully controlled despite treatment with one or two concomitant antiepileptic drugs, in comparison to placebo. Results of
